Company Overview
Epidarex Management Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Wednesday 28 August 2019. Epidarex Management Ltd has been in business for 6 years and 7 months. The accounts status is unaudited abridged and the accounts are next due on Wednesday 30 September 2026.
Registered Address

137A George Street, Edinburgh, EH2 4JY
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameEPIDAREX MANAGEMENT LTD
Company NumberSC640075
Registered Office Address137a George Street
 EH2 4JY
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date28/08/2019
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryUNAUDITED ABRIDGED
Returns Next Due Date25/09/2020
Directors & Members
Andrew Dunlop - Director
(British, 54 years old, born March 1972)
Appointed 28 August 2019
 Active
Peter Finan - Director
(British, 59 years old, born July 1967)
Appointed 27 January 2020
 Active
Elizabeth Roper - Director
(Irish, 52 years old, born July 1974)
Appointed 27 January 2020
 Active
Kyparissia Sirinakis - Director
(American, 61 years old, born June 1965)
Appointed 28 August 2019
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Andrew Dunlop
CLYDE BIOSCIENCES LIMITED
EDINBURGH MOLECULAR IMAGING LIMITED
EPIDAREX PARTNERS LIMITED
INSPIRING SCOTLAND
LARIO THERAPEUTICS LIMITED
MAXCYTE, INC.
REFORM SCOTLAND
SIRAKOSS LIMITED
Peter Finan
ADORX THERAPEUTICS LIMITED
BIOINDUSTRY ASSOCIATION
CALDAN THERAPEUTICS LIMITED
CLYDE BIOSCIENCES LIMITED
CURVE THERAPEUTICS LIMITED
ENTERPRISE THERAPEUTICS HOLDINGS LIMITED
ENTERPRISE THERAPEUTICS LTD
EPIDAREX CAPITAL PARTNERS LIMITED
EPIDAREX EXEED LIMITED
EPSILOGEN LTD
ETERNYGEN UK LTD.
KINSENSUS LIMITED
KNOWLEDGE TRANSFER NETWORK LIMITED
LARIO THERAPEUTICS LIMITED
LEUCID BIO LTD
LUNAC THERAPEUTICS LIMITED
NUTHURST FIBRE PROJECT LTD
THEOLYTICS LTD
THERAVIEW CONSULTING LTD
TMEM16A LIMITED
Elizabeth Roper
CALDAN THERAPEUTICS LIMITED
KYNOS THERAPEUTICS LTD
NODTHERA LIMITED
Kyparissia Sirinakis
EPIDAREX CAPITAL CP, LLP
EPIDAREX CAPITAL FP, LLP
EPIDAREX CAPITAL MANAGEMENT LLP
EPIDAREX CAPITAL PARTNERS LIMITED
EPIDAREX PARTNERS LIMITED
EPSILOGEN LTD
NODTHERA LIMITED
SIRAKOSS LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Balance Sheet
Fixed Assets 8,883 8,883 4,604
Current Assets 111,798 111,798 123,707
Creditors Due Within One Year 753,288 753,288 599,854
Working Cap -641,490 -641,490 -476,147
Total Assets Less Current Liabilities -632,607 -632,607 -471,543
Long-term Liabilities 322,385 322,385 504,107
Net Assets -954,992 -954,992 -975,650
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds -954,992 -954,992 -975,650
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Tangible Fixed Assets - - -
Fixed Assets 7.4% 7.4% 3.6%
Stocks Inventory - - -
Debtors 65.9% 65.9% 68.6%
Cash Bank In Hand 26.7% 26.7% 27.9%
Current Assets 92.6% 92.6% 96.4%
Creditors Due Within One Year 624.2% 624.2% 467.5%
Net Current Assets Liabilities -531.6% -531.6% -371.1%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds -791.3% -791.3% -760.4%
Capital Employed - - -
Total Assets Less Current Liabilities -524.2% -524.2% -367.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Liquidity Ratio 0.1 0.1 0.2
Solvency Ratio 0.1 0.1 0.1
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 4
Mortgages Outstanding 4
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Assets 120,681 120,681 128,311
Debt 1,075,673 1,075,673 1,103,961
Net Assets/Debt -954,992 -954,992 -975,650

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around EH2 4JY
EPIDAREX CAPITAL FP, LLP
137A GEORGE STREET, EDINBURGH, EH2 4JY
EPIDAREX CAPITAL CP, LLP
137A GEORGE STREET, 137A GEORGE STREET, EDINBURGH, EH2 4JY
EPIDAREX CAPITAL MANAGEMENT LLP
137a George Street, Edinburgh, EH2 4JY
EPIDAREX CAPITAL PARTNERS LIMITED
137A GEORGE STREET, EDINBURGH, EH2 4JY
REFORM SCOTLAND
14-18 HILL STREET, EDINBURGH, EH2 4JY
POSITIVE HELP
First Floor Office, 139 George Street, Edinburgh, EH2 4JY
NODTHERA LIMITED
13 QUEENS ROAD, ABERDEEN, EH2 4JY
ETERNYGEN UK LTD.
C/O Epidarex Capital, 137a George Street, Edinburgh, Scotland, EH2 4JY
Document Filings
Confirmation statement made on 27 August 2025 with no updates
Confirmation statement made on 27 August 2024 with no updates
Confirmation statement made on 27 August 2023 with no updates
Confirmation statement made on 27 August 2022 with no updates
Confirmation statement made on 27 August 2021 with no updates
Registration of charge SC6400750004, created on 14 December 2020
Registration of charge SC6400750001, created on 14 December 2020
Registration of charge SC6400750002, created on 14 December 2020
Registration of charge SC6400750003, created on 14 December 2020
Confirmation statement made on 27 August 2020 with updates
Appointment of Dr Elizabeth Ann Roper as a director on 27 January 2020
Current accounting period extended from 31 August 2020 to 31 December 2020
Appointment of Dr Peter Michael Finan as a director on 27 January 2020
Statement of capital following an allotment of shares on 27 January 2020
Notification of Elizabeth Roper as a person with significant control on 27 January 2020
Statement of capital following an allotment of shares on 22 January 2020
Particulars of variation of rights attached to shares
Change of share class name or designation
Resolutions
Incorporation
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free